UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NRIX — Nurix Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in NRIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,277,620
+$838,696 QoQ
Shares Held
135,104
-14.1% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 210 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. NRIX ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in NRIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,277,620 | 135,104 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,438,924 | 157,350 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,202,949 | 168,843 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $906,859 | 98,145 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,643,105 | 232,055 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,895,215 | 159,530 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,764,072 | 146,713 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,887,933 | 128,524 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,685,363 | 128,671 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $1,891,175 | 240,608 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,464,640 | 246,711 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,190,791 | 246,711 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,695,543 | 245,496 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,004,611 | 230,592 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,095,343 | 244,305 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,548,340 | 253,272 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,073,862 | 278,890 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,571,524 | 286,099 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,584,395 | 285,880 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||